Publications by authors named "John Puetz"

Claim this Profile
F
Factor activity levels and bleeding scores in hemophilia carriers: apparent paradoxes.
John Puetz

J Thromb Haemost· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemophilia Gene Therapy: Another Blessing or Another Curse?
John Puetz

Mo Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is confirmatory testing still necessary to diagnose von Willebrand disease?
John Puetz, Krithika Narayana Kumanan, Zidong Zhang

Blood Vessel Thromb Hemost· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor activity levels and bleeding scores in pediatric hemophilia carriers enrolled in the ATHNdataset.
John Puetz, Brian Hu

Pediatr Blood Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergent data influences the risk/benefit assessment of hemophilia gene therapy using recombinant adeno-associated virus.
John Puetz

Front Med (Lausanne)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Liver-related aspects of gene therapy for hemophilia: need for collaborations with hepatologists": comment.
John Puetz

J Thromb Haemost· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptive analysis of bleeding symptoms in haemophilia carriers enrolled in the ATHNdataset.
John Puetz, Dunlei Cheng

Haemophilia· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding during disseminated intravascular coagulation.
John Puetz

J Thromb Haemost· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal aPTT in children with mild factor XI deficiency.
John Puetz, Christopher Hugge, Karen Moser

Pediatr Blood Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the gene encoding calcium and diacylglycerol regulated guanine nucleotide exchange factor I (CalDAG-GEFI) in human patients with congenital qualitative platelet disorders.
John Puetz, Mary K Boudreaux

Platelets· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Widespread use of fresh frozen plasma in US children's hospitals despite limited evidence demonstrating a beneficial effect.
John Puetz, Char Witmer, Yuan-Shung V Huang, Leslie Raffini

J Pediatr· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients.
John Puetz

Drug Des Devel Ther· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma.
John Puetz, Ginger Darling, Petr Brabec, Jan Blatny, Prasad Mathew

Pediatr Blood Cancer· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fresh frozen plasma and recombinant factor VIIa use in neonates.
John Puetz, Ginger Darling, Kimberly A McCormick, Jonathan D Wofford

J Pediatr Hematol Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet function disorder in Gardner-Diamond syndrome: a case report and review of the literature.
John Puetz, Timothy Fete

J Pediatr Hematol Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital deficiency of vitamin K-dependent coagulation factors associated with central nervous system anomalies.
John Puetz, Al Knutsen, John Bouhasin

Thromb Haemost· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of recombinant factor vila to control bleeding in an adolescent male with severe hemophilia A, HIV thrombocytopenia, hepatitis C, and end-stage liver disease.
John J Puetz, John D Bouhasin

Am J Hosp Palliat Care· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis